Sharescart Research Club logo

Medplus Health Servi Overview

MedPlus Health Services Ltd engages in the retail buying and selling of medicines and general items in India. It offers pharmaceutical and wellbeing products, including medicines, vitamins, medical gadgets, and test kits; fast-shifting customer goods, such as toiletries, infant care products, soaps, detergents, and sanitizers. The organisation additionally offers wholesale cash and carry, and pathological laboratory testing offerings, in addition to engages within the settlement manufacturing of private label prescribed drugs. As of March 31, 2...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Medplus Health Servi Key Financials

Market Cap ₹10538 Cr.

Stock P/E 70.1

P/B 5.5

Current Price ₹877.8

Book Value ₹ 158.5

Face Value 2

52W High ₹1052.1

Dividend Yield 0%

52W Low ₹ 732

Medplus Health Servi Share Price

₹ | |

Volume
Price

Medplus Health Servi Quarterly Price

Show Value Show %

Medplus Health Servi Peer Comparison

Medplus Health Servi Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 1409 1441 1490 1489 1576 1561 1510 1543 1679 1806
Other Income 10 10 10 9 12 13 16 15 17 18
Total Income 1419 1451 1501 1498 1588 1574 1525 1558 1697 1824
Total Expenditure 1323 1350 1385 1395 1452 1429 1373 1412 1530 1648
Operating Profit 95 102 116 102 136 145 152 146 166 177
Interest 24 24 25 25 25 26 27 27 29 31
Depreciation 55 57 59 60 63 62 64 66 69 73
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 16 20 32 18 48 57 61 53 69 73
Provision for Tax 2 6 -2 3 9 11 10 10 13 15
Profit After Tax 15 14 34 14 39 46 51 42 56 58
Adjustments 0 0 -0 0 0 0 0 0 -0 0
Profit After Adjustments 15 14 33 14 39 46 51 42 56 58
Adjusted Earnings Per Share 1.2 1.1 2.8 1.2 3.2 3.8 4.3 3.5 4.6 4.8

Medplus Health Servi Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1368 1733 2011 2132 2273 2871 3069 3779 4558 5625 6136 6538
Other Income 4 9 8 7 10 17 22 31 46 40 49 66
Total Income 1373 1742 2020 2139 2283 2888 3091 3811 4604 5665 6185 6604
Total Expenditure 1333 1691 1935 2073 2216 2737 2840 3490 4276 5254 5633 5963
Operating Profit 40 50 85 66 67 151 251 320 327 411 552 641
Interest 17 22 25 28 16 47 67 83 99 114 119 114
Depreciation 9 10 11 12 14 75 88 119 182 224 250 272
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 14 19 48 26 37 29 95 118 47 73 183 256
Provision for Tax 6 10 19 -17 16 28 32 23 -3 8 33 48
Profit After Tax 7 9 29 42 21 2 63 95 50 66 150 207
Adjustments 0 -0 -0 0 0 0 1 1 -0 -0 0 0
Profit After Adjustments 7 9 29 42 21 2 64 96 50 65 150 207
Adjusted Earnings Per Share 39.4 47.8 152.3 194.1 95.8 8.2 285.1 8 4.2 5.5 12.6 17.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 18% 16% 16%
Operating Profit CAGR 34% 20% 30% 30%
PAT CAGR 127% 16% 137% 36%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 10% 6% NA% NA%
ROE Average 9% 6% 7% 9%
ROCE Average 18% 13% 16% 15%

Medplus Health Servi Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 154 149 160 303 325 528 731 1418 1491 1578 1741
Minority's Interest 0 0 0 0 0 1 1 -1 -1 -1 -1
Borrowings 62 65 54 8 0 0 0 0 0 0 0
Other Non-Current Liabilities 5 18 34 -27 10 327 399 647 797 849 992
Total Current Liabilities 210 269 276 325 337 498 445 559 477 575 625
Total Liabilities 430 501 525 610 672 1354 1575 2624 2764 3002 3356
Fixed Assets 67 77 81 83 90 419 517 799 1138 1242 1296
Other Non-Current Assets 46 48 49 69 107 102 105 193 146 143 168
Total Current Assets 317 376 395 458 475 833 953 1632 1481 1616 1891
Total Assets 430 501 525 610 672 1354 1575 2624 2764 3002 3356

Medplus Health Servi Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 13 46 31 21 35 -47 9 -28 -121 228 91
Cash Flow from Operating Activities -19 -17 34 32 82 -7 3 170 90 144 540
Cash Flow from Investing Activities -15 -32 -15 -18 -20 -28 -35 -703 429 -83 -318
Cash Flow from Financing Activities 66 35 -29 -1 -72 90 -6 440 -170 -198 -228
Net Cash Inflow / Outflow 32 -15 -10 14 -10 56 -37 -93 350 -137 -5
Closing Cash & Cash Equivalent 45 31 21 35 24 9 -28 -121 228 91 86

Medplus Health Servi Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 39.43 47.84 152.33 194.06 95.77 8.22 285.08 8.03 4.17 5.48 12.56
CEPS(Rs) 85.43 100.33 212.89 251.21 159.72 350.98 675.81 17.94 19.42 24.24 33.42
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 716.21 694.75 752.08 1363.1 1450.49 2378.5 3044.19 117.89 122.44 129.47 143.22
Core EBITDA Margin(%) 2.61 2.39 3.81 2.75 2.5 4.65 7.32 7.54 6.08 6.51 8.09
EBIT Margin(%) 2.28 2.33 3.65 2.5 2.32 2.65 5.19 5.24 3.16 3.28 4.86
Pre Tax Margin(%) 1.01 1.08 2.38 1.2 1.61 1.02 3.04 3.08 1.02 1.29 2.95
PAT Margin (%) 0.55 0.52 1.43 1.99 0.92 0.06 2.01 2.47 1.08 1.15 2.41
Cash Profit Margin (%) 1.18 1.1 2 2.57 1.53 2.67 4.83 5.59 5.01 5.08 6.43
ROA(%) 1.73 1.94 5.62 7.47 3.26 0.18 4.31 4.51 1.86 2.27 4.73
ROE(%) 5.51 6.78 21.06 19.26 6.81 0.43 10.51 9.07 3.5 4.36 9.21
ROCE(%) 10.02 12.04 20.61 13.06 11.77 14.34 21.69 16.56 9.56 12.19 18.22
Receivable days 1.03 0.77 0.53 1.09 1.53 0.96 0.69 0.54 0.58 0.84 0.9
Inventory Days 67.6 59.37 58.51 59.74 60.81 65.93 81.18 79.28 81.27 79.52 78.76
Payable days 34.09 28.02 24.9 25.21 28.85 31 28.76 24.13 25.98 21.33 21.71
PER(x) 0 0 0 0 0 0 0 125.8 156.11 125.87 60.48
Price/Book(x) 0 0 0 0 0 0 0 8.57 5.32 5.33 5.3
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.09 0.1 0.08 0.05 0.02 -0.01 0.01 3.22 1.64 1.44 1.42
EV/Core EBITDA(x) 3.07 3.44 1.92 1.59 0.82 -0.23 0.07 37.97 22.86 19.69 15.8
Net Sales Growth(%) 0 26.64 16.07 5.99 6.61 26.31 6.92 23.13 20.59 23.42 9.09
EBIT Growth(%) 0 29.35 81.5 -27.21 -1.32 44.56 113.38 23.63 -27.38 28.24 61.55
PAT Growth(%) 0 21.32 218.43 46.9 -50.65 -91.42 3417.89 50.08 -47.1 30.88 129.09
EPS Growth(%) 0 21.31 218.43 27.39 -50.65 -91.42 3368.17 -97.18 -48.06 31.32 129.29
Debt/Equity(x) 1.07 1.46 1.24 0.55 0.33 0.2 0.2 0.1 0 0 0
Current Ratio(x) 1.51 1.4 1.43 1.41 1.41 1.67 2.14 2.92 3.11 2.81 3.03
Quick Ratio(x) 0.3 0.25 0.22 0.29 0.24 0.38 0.46 1.28 0.71 0.48 0.87
Interest Cover(x) 1.79 1.86 2.89 1.92 3.27 1.63 2.41 2.42 1.48 1.65 2.54
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.01 0 0 0

Medplus Health Servi Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 40.45 40.39 40.39 40.39 40.39 40.34 40.32 40.29 40.29 40.22
FII 12.97 14.94 14.85 14.72 15.23 15.61 16.42 16.54 16.83 15.53
DII 25.18 22.47 22.17 27.97 25.65 26.19 26.03 26.52 26.57 27.82
Public 21.4 22.2 22.59 16.92 18.73 17.87 17.22 16.65 16.3 16.44
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Medplus Health Servi News

Medplus Health Servi Pros & Cons

Pros

  • Company has delivered good profit growth of 137% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Promoter holding is low: 40.22%.
  • Company has a low return on equity of 6% over the last 3 years.
  • Debtor days have increased from 21.33 to 21.71days.
  • Stock is trading at 5.5 times its book value.
whatsapp